Applying Bayesian Decision Lists to Diverse Industries

Publication ID: 24-11857322_0002_PTD
Published: November 07, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Applying Bayesian Decision Lists to Diverse Industries,” Published Technical Disclosure No. 24-11857322_0002_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857322_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,322.

Summary of the Inventive Concept

This inventive concept leverages the core technology of Bayesian Decision Lists to develop novel applications in various industries, including agriculture, supply chain logistics, marketing, energy consumption, and manufacturing.

Background and Problem Solved

The original patent disclosed systems and methods for screening, diagnosing, and stratifying patients relating to neuropsychiatric diseases. However, the potential of Bayesian Decision Lists extends far beyond healthcare. This inventive concept addresses the limitation of the original patent by applying the core technology to entirely new industries, solving complex problems in these fields.

Detailed Description of the Inventive Concept

The new inventive concept involves the development of systems and methods that utilize Bayesian Decision Lists to tackle challenges in diverse industries. For instance, in agriculture, the system can predict crop yields based on historical climate data and crop yield information. In supply chain logistics, the Bayesian Decision List can optimize logistics by identifying factors affecting efficiency. Similarly, in marketing, the system can evaluate the effectiveness of marketing campaigns by analyzing consumer response data. In energy consumption, the system can predict energy consumption patterns based on historical data and environmental factors. Finally, in manufacturing, the Bayesian Decision List can optimize resource allocation by identifying factors affecting manufacturing efficiency.

Novelty and Inventive Step

The new claims introduce novel applications of Bayesian Decision Lists in industries unrelated to healthcare, which were not considered in the original patent. The inventive step lies in the adaptation of the core technology to address specific challenges in these new industries, resulting in innovative solutions with significant commercial potential.

Alternative Embodiments and Variations

Alternative embodiments of this inventive concept could include the integration of additional data sources, such as IoT sensors or social media data, to enhance the predictive capabilities of the Bayesian Decision Lists. Variations could also involve the development of specialized Bayesian Decision Lists tailored to specific industries or use cases.

Potential Commercial Applications and Market

The commercial potential of this inventive concept is substantial, with potential applications in multiple industries. The target market includes companies operating in agriculture, supply chain logistics, marketing, energy consumption, and manufacturing, as well as startups and research institutions seeking to leverage AI and machine learning for innovation.

Field of Art

Machine learning, predictive analytics, and computational decision support systems with expertise in Bayesian modeling, data processing, and multi-domain predictive modeling techniques

Person of Ordinary Skill (PHOSITA) Profile

A skilled practitioner with advanced degrees in computer science, statistics, or engineering, proficient in machine learning algorithms, data analysis, and computational modeling across multiple technical domains

Obviousness Rationale

The PTD demonstrates that the core Bayesian Decision List methodology from the source patent can be readily adapted to diverse industrial contexts by applying the same fundamental machine learning principles. A PHOSITA would recognize that the underlying computational approach of processing input features through probabilistic decision trees remains consistent across domains. The technical transfer involves substituting domain-specific input features while maintaining the core algorithmic structure, which represents a predictable engineering adaptation.

Obvious Combinations & Variations

Source Patent Element
Bayesian Decision List processing system for evaluating mental health conditions
PTD Variation
Applying Bayesian Decision List to agricultural crop yield prediction
Obviousness Reasoning
Known technique of transferring machine learning algorithms across domains with domain-specific feature substitution, representing a predictable result of algorithmic generalization
Source Patent Element
Input feature processing using cognitive task outcome measures
PTD Variation
Processing supply chain efficiency factors using equivalent probabilistic modeling
Obviousness Reasoning
Predictable extension of feature-based probabilistic modeling to alternative complex systems with measurable input parameters
Source Patent Element
Machine executable code for generating diagnostic predictions
PTD Variation
Generating predictive models for marketing campaign effectiveness
Obviousness Reasoning
Routine application of existing computational methodology to new problem domain with substantially similar computational requirements
Source Patent Element
Control system configured to determine condition probabilities
PTD Variation
Energy consumption pattern prediction using machine learning algorithms
Obviousness Reasoning
Obvious design choice to adapt existing probabilistic decision support framework to alternative predictive modeling scenarios
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857322, a person having ordinary skill in the art would find the disclosed variations in predictive modeling techniques obvious and anticipated, as the fundamental computational approach of Bayesian Decision List processing remains substantively unchanged when applied across diverse technical domains, thereby rendering potential claims of novelty invalid under standard obviousness analysis.

Original Patent Information

Patent NumberUS 11,857,322
TitleSystems and methods for screening, diagnosing, and stratifying patients
Assignee(s)Neumora Therapeutics, Inc.